Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Pawel et al. (Mon,) studied this question.

synapsesocial.com/papers/69d98e7a387cf706986847e7 — DOI: https://doi.org/10.1200/jco.1999.17.2.658

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer· 1995 · 26 citations
2. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.· 1992 · 452 citations
3. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial· 1996 · 224 citations
4. Phase II Study of Vinorelbine in Heavily Previously Treated Small Cell Lung Cancer· 2009 · 83 citations
5. Management of small-cell cancer of the lung· 1992 · 87 citations